National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 41048 [2015-17160]
Download as PDF
<![CDATA[
asabaliauskas on DSK5VPTVN1PROD with NOTICES
41048
Federal Register / Vol. 80, No. 134 / Tuesday, July 14, 2015 / Notices
topic. At least 7 minutes will be allotted
for each speaker, and if time permits,
may be extended up to 10 minutes at the
discretion of the chair. Registration for
oral comments will also be available onsite, although time allowed for
presentation by on-site registrants may
be less than for registered speakers and
will be determined by the number of
persons who register at the meeting. In
addition to in-person oral comments at
the meeting, public comments can be
presented by teleconference line. There
will be 50 lines for this call; availability
will be on a first-come, first-served
basis. The lines will be open from 8:30
a.m. until approximately 5:00 p.m.,
although public comments will be
received only during the formal public
comment periods, which will be
indicated on the preliminary agenda.
The access number for the
teleconference line will be provided to
registrants by email prior to the meeting.
Persons wishing to present oral
comments are encouraged to register
using the SACATM meeting registration
form (https://ntp.niehs.nih.gov/go/
32822), indicate the topic(s) on which
they plan to comment, and, if possible,
send a copy of their statement to
whiteld@niehs.nih.gov by August 26,
2015, to enable review by SACATM,
NICEATM, ICCVAM, and NIEHS/NTP
staff prior to the meeting. Written
statements can supplement and may
expand the oral presentation. If
registering on-site and reading from
written text, please bring 20 copies of
the statement for distribution and to
supplement the record.
Background Information on ICCVAM,
NICEATM, and SACATM: ICCVAM is
an interagency committee composed of
representatives from 15 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
with regulatory applicability and
promotes the scientific validation and
regulatory acceptance of toxicological
and safety-testing methods that more
accurately assess the safety and hazards
of chemicals and products and that
reduce, refine (decrease or eliminate
pain and distress), or replace animal
use. The ICCVAM Authorization Act of
2000 (42 U.S.C. 285l–3) established
ICCVAM as a permanent interagency
committee of the NIEHS under
NICEATM.
NICEATM administers ICCVAM,
provides scientific and operational
support for ICCVAM-related activities,
and conducts independent validation
studies to assess the usefulness and
VerDate Sep<11>2014
19:09 Jul 13, 2015
Jkt 235001
limitations of new, revised, and
alternative test methods and strategies.
NICEATM and ICCVAM work
collaboratively to evaluate new and
improved test methods and strategies
applicable to the needs of U.S. federal
agencies. NICEATM and ICCVAM
welcome the public nomination of new,
revised, and alternative test methods
and strategies for validation studies and
technical evaluations. Additional
information about ICCVAM and
NICEATM can be found at https://
ntp.niehs.nih.gov/go/iccvam and https://
ntp.niehs.nih.gov/go/niceatm.
SACATM was established in response
to the ICCVAM Authorization Act
[Section 285l–3(d)] and is composed of
scientists from the public and private
sectors. SACATM advises ICCVAM,
NICEATM, and the Director of the
NIEHS and NTP regarding statutorily
mandated duties of ICCVAM and
activities of NICEATM. SACATM
provides advice on priorities and
activities related to the development,
validation, scientific review, regulatory
acceptance, implementation, and
national and international
harmonization of new, revised, and
alternative toxicological test methods.
Additional information about SACATM,
including the charter, roster, and
records of past meetings, can be found
at https://ntp.niehs.nih.gov/go/167.
Dated: July 8, 2015.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2015–17165 Filed 7–13–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00058
Fmt 4703
Sfmt 9990
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implantation Grant (R01).
Date: August 17, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: 5061 Fishers Lane, Conference
Room 3F100, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Paul Roberts, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G22, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Rockville, MD 20852, 240–669–5053,
paul.roberts@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implantation Grant (R01).
Date: August 18, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: 5601 Fishers Lane, Conference
Room 3F100, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Paul Roberts, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G22, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Rockville, MD 20852, 240–669–5053,
paul.roberts@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implantation Cooperative Agreement (U01).
Date: August 19, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: 5601 Fishers Lane, Conference
Room 3F100, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Paul Roberts, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G22, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Rockville, MD 20852, 240–669–5053,
paul.roberts@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 8, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–17160 Filed 7–13–15; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\14JYN1.SGM
14JYN1
]]>Agencies
[Federal Register Volume 80, Number 134 (Tuesday, July 14, 2015)]
[Notices]
[Page 41048]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-17160]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Clinical Trial Implantation
Grant (R01).
Date: August 17, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: 5061 Fishers Lane, Conference Room 3F100, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Paul Roberts, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, Room
3G22, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC
9823, Rockville, MD 20852, 240-669-5053, paul.roberts@nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Clinical Trial Implantation
Grant (R01).
Date: August 18, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: 5601 Fishers Lane, Conference Room 3F100, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Paul Roberts, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, Room
3G22, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC
9823, Rockville, MD 20852, 240-669-5053, paul.roberts@nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Clinical Trial Implantation
Cooperative Agreement (U01).
Date: August 19, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: 5601 Fishers Lane, Conference Room 3F100, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Paul Roberts, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, Room
3G22, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC
9823, Rockville, MD 20852, 240-669-5053, paul.roberts@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: July 8, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-17160 Filed 7-13-15; 8:45 am]
BILLING CODE 4140-01-P
